Digital PCR (dPCR) Gains Ground in Forensic DNA Analysis
How next-generation partitioning technology is transforming the way crime labs handle degraded and trace-level DNA evidence
In the quiet but consequential world of forensic genetics, a technological shift is well underway. Global forensic laboratories — from the U.S. Federal Bureau of Investigation's Laboratory Division to specialist units at King's College London — are actively transitioning toward Digital PCR (dPCR) as a frontline tool for handling some of the most challenging biological evidence in modern criminal justice: severely degraded DNA. For budding forensic scientists, this is a development worth watching closely. It is not merely an upgrade; it represents a fundamental rethinking of how DNA is measured at crime scenes.
🧪 What Is Digital PCR — And Why Does It Matter?
To appreciate why dPCR is exciting forensic scientists, it helps to understand the problem it solves. Traditional quantitative PCR (qPCR) has been the workhorse of forensic DNA quantification for over two decades. But qPCR is a relative measurement — it estimates DNA concentration against external standard curves, introducing variability between labs, susceptibility to PCR inhibitors found in soil, blood, and environmental contaminants, and unreliability when dealing with severely fragmented genetic material.
Digital PCR works on a radically different principle. A single DNA sample is physically partitioned into thousands of tiny individual reactions — each droplet or nanowell either contains a target DNA molecule or it does not. After amplification, the system simply counts: positive partitions versus negative ones. Using Poisson statistics, it calculates the absolute number of target copies present — no external standards needed.
A DNA extract is loaded onto a nanoplate (or converted into water-in-oil droplets in droplet dPCR). The sample disperses into thousands of individual micro-reactions. Each is thermally cycled. At the endpoint, a fluorescence reader scans every partition and records it as a binary "1" (target present) or "0" (absent). The ratio of positive to total valid partitions is fed into a Poisson distribution model to yield an absolute copy number — with no reliance on calibration curves or amplification efficiency assumptions.
🏛️ FBI & QIAGEN: A Landmark Partnership
The most high-profile validation of dPCR's forensic potential came in May 2024, when QIAGEN — the global leader in forensic DNA solutions — announced a Cooperative Research and Development Agreement (CRADA) with the FBI Laboratory Division. The collaboration aims to develop the first-of-its-kind dPCR assay capable of simultaneously quantifying nuclear DNA, mitochondrial DNA (mtDNA), and male-specific DNA, while also incorporating markers for inhibition and degradation severity — all in a single analytical run.
QIAGEN's QIAcuity platform — the instrument at the centre of this collaboration — uses nanoplates to partition a sample across thousands of individual reactions, reading each simultaneously to deliver precise, binary results. The platform's high tolerance to PCR inhibitors (compounds that routinely compromise qPCR performance in soiled, aged, or environmental samples) makes it particularly well-suited for real-world crime scene evidence. In January 2025, QIAGEN further expanded QIAcuity's capabilities with a two-fold increase in the number of targets that can be analysed simultaneously from a single biological sample.
📊 dPCR vs Traditional qPCR: A Head-to-Head Comparison
| Feature | Traditional qPCR | Digital PCR (dPCR) |
|---|---|---|
| Quantification method | Relative (needs standard curves) | Absolute (no standards required) |
| Inhibitor tolerance | ✗ Low — inhibitors skew results | ✓ High — partitioning dilutes inhibitors |
| Degraded DNA performance | ✗ Poor — short fragments often missed | ✓ Excellent — detects as few as 2 copies |
| Cross-lab reproducibility | Moderate (standard-dependent) | High (standard-independent) |
| mtDNA quantification | Limited / indirect | ✓ Direct absolute quantification |
| Setup complexity | Moderate | Similar to qPCR |
| Throughput (single run) | Up to 96 wells | Up to 94 samples + controls |
| Court-readiness of data | Established precedent | Emerging — validation underway |
🔬 The Science: How dPCR Handles Degraded DNA
Degraded DNA is one of the most persistent and frustrating challenges in forensic casework. When a biological sample is exposed to heat, UV radiation, soil microbes, humidity, or simply the passage of time, the DNA begins to fragment into progressively shorter pieces. Conventional methods struggle here because they require intact amplifiable regions — regions that degraded samples often simply cannot supply.
A landmark 2025 study published in Forensic Science International (Central South University, China) demonstrated just how powerfully dPCR addresses this problem. Researchers developed a triplex droplet digital PCR (ddPCR) system targeting three autosomal conserved regions with amplification lengths of 75 bp, 145 bp, and 235 bp simultaneously. By calculating a "Degradation Rate" (DR) — the ratio of detectable copies across these three fragment sizes — the system could precisely map how severely a sample had degraded, even detecting DNA quality from specimens containing as few as two target copies.
The study tested the approach on real forensic casework samples including formalin-fixed paraffin-embedded (FFPE) cardiac and pulmonary tissues and aged blood samples from 2022–2024 cases. The results demonstrated that this ddPCR-based triage approach could effectively guide laboratories toward the optimal downstream analysis workflow — whether standard CE-based STR typing or next-generation sequencing — saving both time and resources.
🎓 Academic Validation: King's College London Weighs In
Academic institutions are equally invested. Researchers at King's College London — one of the UK's premier forensic genetics centres, accredited for specialist low-level casework and complex kinship analysis — have been at the forefront of evaluating dPCR for routine forensic workflows. In a widely-cited QIAGEN-hosted webinar, Dr. David Ballard and Michael Menear of King's highlighted that:
- Mitochondrial DNA quantification by dPCR is ready for casework implementation following validation, and is expected to be introduced into live casework in the near term.
- Single-copy nuclear DNA assays have been successfully implemented on the QIAcuity platform as a direct replacement for qPCR quantification — and the absence of calibration standards simplifies setup while reducing variability.
- RNA-based body fluid identification assays using dPCR show strong promise, with saliva and other body fluids identifiable via human-specific digital PCR probes.
🔄 How dPCR Fits Into the Forensic Workflow
-
1Crime Scene Collection Biological evidence (blood, hair, bone, touch DNA, aged stains) collected. Often degraded or heavily contaminated with soil, plant matter, or environmental inhibitors.
-
2DNA Extraction Standard laboratory extraction protocols applied. Extract may contain very low template quantities and/or PCR inhibitors.
-
3dPCR Quantification & Triage Extract loaded onto dPCR platform. Absolute copy numbers of nuclear DNA, mitochondrial DNA, and male DNA determined simultaneously. Degradation rate calculated. Analysts receive an objective decision framework for routing samples to STR typing or NGS.
-
4STR Profiling / Next-Generation Sequencing Based on dPCR triage, well-quantified samples proceed to capillary electrophoresis (CE-STR) or massively parallel sequencing (MPS/NGS) for full genetic profiling.
-
5Database Comparison & Reporting Generated profiles compared against national DNA databases (e.g., CODIS in the U.S., NDNAD in the U.K.) and reported to investigating authorities with strengthened statistical confidence.
🌍 Global Standardisation: NIST Steps Up
A critical enabler for any new forensic technology is standardised reference materials — benchmarks that allow laboratories worldwide to calibrate and validate their methods. In a timely development, the National Institute of Standards and Technology (NIST) released a new forensic DNA reference material, RM 8043, in early 2026 — the first such reference material to include both degraded DNA and mixtures of high-quality DNA from multiple individuals.
Before its public release, NIST distributed RM 8043 to approximately 100 forensic laboratories for collaborative testing. The material is designed to let labs validate new instruments and methods — including dPCR-based workflows — against known genetic profiles. As NIST researcher Peter Vallone explained: "These samples act as ground truth. Genetics laboratories can use the samples to kick the tires and make sure that a new instrument or technology is working as it should."
📈 Market Momentum: An Industry in Acceleration
The forensic world's embrace of dPCR is happening against a backdrop of extraordinary market growth. The global dPCR market — which spans clinical diagnostics, oncology research, infectious disease testing, and forensics — was valued at USD 8.42 billion in 2024 and is projected to reach USD 23.15 billion by 2035, at a compound annual growth rate (CAGR) of 9.4%. The forensics application segment, while smaller, is growing proportionally as more national laboratories add dPCR capability to their analytical suites.
Key industry players advancing dPCR technology for forensic applications include QIAGEN (QIAcuity platform), Bio-Rad Laboratories (QX600 Droplet Digital PCR), Stilla Technologies (Naica system), and Thermo Fisher Scientific (QuantStudio Absolute Q). In 2025, Bio-Rad entered acquisition proceedings for Stilla Technologies — a move expected to consolidate the droplet dPCR market significantly.
⚠️ Challenges Still to Overcome
Despite the momentum, forensic scientists are right to approach dPCR implementation with structured caution. Several challenges remain:
Courtroom Admissibility: Any new forensic method must satisfy judicial standards for scientific evidence (such as the Daubert standard in the U.S.). While qPCR has decades of established case law behind it, dPCR is still accumulating the validation literature and cross-laboratory studies needed for uncontested courtroom acceptance.
Validation Burden: Forensic laboratories operate under strict accreditation frameworks (ISO 17025, ASCLD). Before any new method enters casework, it must undergo comprehensive internal validation — a resource-intensive process that can take months to years.
Body Fluid RNA Assays: While RNA-based body fluid identification by dPCR shows great promise, researchers at King's College London note that saliva samples in particular present challenges due to the high proportion of bacterial nucleic acids that can interfere with human-specific measurements. Further cross-donor and cross-sample-type testing is underway.
Cost and Infrastructure: dPCR instruments represent a significant capital investment. Not all forensic laboratories — particularly in lower-resource jurisdictions — will have immediate access to this technology.
💡 What This Means for Budding Forensic Scientists
If you are studying forensic science or planning a career in forensic DNA analysis, dPCR is a technology you need to understand — and soon. As national laboratories like the FBI Laboratory, the UK's Forensic Science Service successors, and academic partners like King's College London integrate dPCR into validated workflows, employers will increasingly expect familiarity with the platform.
More broadly, dPCR is part of a wider technological revolution reshaping the forensic DNA discipline — alongside Next-Generation Sequencing (NGS), Rapid DNA analysis, AI-driven interpretation software, and advanced bioinformatics. The forensic scientists of the next decade will need to be conversant not just in classical STR typing, but in these converging digital and molecular technologies.
- dPCR delivers absolute quantification of DNA without external standards — a major advantage for degraded, trace, and inhibited forensic samples.
- The FBI–QIAGEN partnership (May 2024) marks institutional validation of dPCR as a serious forensic tool.
- Mitochondrial DNA quantification by dPCR is the closest to immediate casework adoption; body fluid RNA identification is next in the pipeline.
- NIST RM 8043 (2026) gives labs a validated degraded-DNA reference material to test dPCR workflows against — accelerating global adoption.
- The dPCR market is on a strong growth trajectory, pointing toward widespread laboratory infrastructure investment in the coming years.
Digital PCR is not coming to forensic laboratories — it is already here, being validated in casework pipelines by some of the world's most respected forensic science institutions. For a discipline where the difference between usable and unusable evidence can determine justice, the ability to reliably extract absolute genetic information from even the most degraded and compromised biological material is not just a technological advantage. It is a moral imperative. Watch this space — the dPCR revolution in forensic DNA analysis is only just beginning.
📚 Sources & Further Reading
- QIAGEN Press Release — QIAGEN partners with FBI to develop digital PCR assay for forensics (May 7, 2024). Read source ↗
- QIAGEN Knowledge Hub — Why digital PCR is gaining ground in forensic analysis (featuring King's College London researchers). Read source ↗
- Chen et al. (2025) — A novel droplet digital PCR method for assessing the quantity and quality of degraded samples. Forensic Science International, Vol. 368, Article 112408. Read source ↗
- NIST News (February 2026) — NIST Releases New Forensic Genetic Reference Material to Help Crime Laboratories Analyze Challenging Cases (RM 8043). Read source ↗
- Roots Analysis — Digital PCR Market Size, Share & Industry Trends [2035]. Read source ↗
- PMC / RSC (2025) — Digital PCR: from early developments to its future application in clinics. Read source ↗
- SciEPublish (2024) — Emerging Technologies in Forensic DNA Analysis. Perspectives in Legal and Forensic Sciences, 1(1), 10007. Read source ↗
- MDPI Genes (November 2025) — Analysis of Human Degraded DNA in Forensic Genetics. Read source ↗
- Separation Science (June 2025) — Degraded DNA Analysis Techniques: Purification, Characterization, and Forensic Workflows. Read source ↗
- Biometric Update (May 2024) — QIAGEN, FBI partner to enhance forensic DNA analysis. Read source ↗
ⓘ This article is for educational purposes. All information is sourced from publicly available peer-reviewed journals, institutional press releases, and market research reports. © 2026 Budding Forensic Expert. All rights reserved.
